Mindfulness Training for Smoking Cessation
- Conditions
- Tobacco SmokingSmoking CessationCigarette SmokingNicotine Dependence
- Interventions
- Behavioral: Smoking Cessation TherapyBehavioral: Mindfulness Training
- Registration Number
- NCT01144689
- Lead Sponsor
- Yale University
- Brief Summary
The purpose of this study is to assess the effects of mindfulness training (MT) compared to standard Smoking Cessation Therapy (SCT) on smoking cessation and stress provocation in individuals trying to quit smoking.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 42
- Between the ages of 18 and 60
- Smoking 10 or more cigarettes per day
- Fewer than 3 months of smoking abstinence in the past year
- Motivated to stop smoking
- Current use of psychoactive medications that have not been at a stable dose for the past six months, are used as mood stabilizers, or are used as smoking cessation treatments. Individuals who are on psychoactive medications that are stable, not mood stabilizers, and not used for smoking cessations are excluded from fMRI sessions but not smoking cessation treatment.
- Use of another investigational drug within 30 days
- Any serious or unstable disease within 6 months
- Meets criteria for substance dependence within the past year
- Left handed (will be excluded from fMRI only)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Smoking Cessation Therapy Smoking Cessation Therapy - Mindfulness Training Mindfulness Training -
- Primary Outcome Measures
Name Time Method Between group differences in continuous abstinence during treatment and 6, 12 and 18 weeks after treatment initiation
- Secondary Outcome Measures
Name Time Method Between group differences in perceived stress 6, 12 and 18 weeks after treatment initiation
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
VA Connecticut Healthcare System
šŗšøWest Haven, Connecticut, United States